Predictors of Progression and Mortality in Patients with Prevalent Rheumatoid Arthritis and Interstitial Lung Disease: A Prospective Cohort Study.
Natalia Mena VázquezMarta Rojas-GimenezCarmen María Romero-BarcoSara Manrique ArijaEspildora FranciscoMaría Carmen Aguilar-HurtadoIsabel Añón-OñateLorena Pérez-AlbaladejoRafaela Ortega-CastroFrancisco Javier Godoy-NavarreteInmaculada Ureña-GarnicaMaria Luisa Velloso-FeijooRocio Redondo-RodriguezFrancisco Gabriel Jimenez-NúñezBlanca Panero LamotheMaría Isabel Padin-MartínAntonio Fernandez-NebroPublished in: Journal of clinical medicine (2021)
Lung function is stable in most patients with RA-ILD receiving treatment with disease-modifying anti-rheumatic drugs (DMARDs), although one-third worsened or died. Identifying factors associated with worsening in RA-ILD is important for clinical management.
Keyphrases
- interstitial lung disease
- rheumatoid arthritis
- lung function
- systemic sclerosis
- disease activity
- cystic fibrosis
- chronic obstructive pulmonary disease
- air pollution
- idiopathic pulmonary fibrosis
- ankylosing spondylitis
- cardiovascular events
- cardiovascular disease
- risk factors
- coronary artery disease
- replacement therapy